93 related articles for article (PubMed ID: 21519024)
21. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
22. [The role of intraoperative gamma-probe-guided sentinel lymph node biopsy in the treatment of malignant melanoma and breast cancer].
Péley G; Sinkovics I; Liszkay G; Tóth J; Péter I; Farkas E; Téglás M; Hrívó A; Füzy M; Gilde K; Köves I
Orv Hetil; 1999 Oct; 140(42):2331-8. PubMed ID: 10560260
[TBL] [Abstract][Full Text] [Related]
23. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.
Valsecchi ME; Silbermins D; de Rosa N; Wong SL; Lyman GH
J Clin Oncol; 2011 Apr; 29(11):1479-87. PubMed ID: 21383281
[TBL] [Abstract][Full Text] [Related]
25. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in the diagnosis and treatment of multicentric malignant melanoma of the penis.
Miller E; Barnea Y; Karin E; Leshem D; Weiss J; Leider-Trejo L; Schneebaum S
Isr Med Assoc J; 2006 Apr; 8(4):292-3. PubMed ID: 16671371
[No Abstract] [Full Text] [Related]
27. Cutaneous melanoma: a model to study cancer metastasis.
Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
[TBL] [Abstract][Full Text] [Related]
28. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
29. Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap.
Riber-Hansen R; Nyengaard JR; Hamilton-Dutoit SJ; Steiniche T
Cancer; 2009 May; 115(10):2177-87. PubMed ID: 19288568
[TBL] [Abstract][Full Text] [Related]
30. New developments in sentinel node staging in melanoma: controversies and alternatives.
van Akkooi AC; Voit CA; Verhoef C; Eggermont AM
Curr Opin Oncol; 2010 May; 22(3):169-77. PubMed ID: 20168231
[TBL] [Abstract][Full Text] [Related]
31. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
32. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node mapping for melanoma: results of trials and current applications.
Thompson JF; Shaw HM
Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
[TBL] [Abstract][Full Text] [Related]
34. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma.
Sondak VK; Zager JS; Messina JL; Thomas JM
Clin Adv Hematol Oncol; 2007 Jun; 5(6):483-90. PubMed ID: 17679922
[No Abstract] [Full Text] [Related]
37. Results of sentinel lymph node biopsy in patients with thin melanoma.
Wong SL; Brady MS; Busam KJ; Coit DG
Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151
[TBL] [Abstract][Full Text] [Related]
38. [Sentinel lymph node biopsy and incidence of recurrence].
Hautarzt; 2006 Mar; 57(3):182. PubMed ID: 17429861
[No Abstract] [Full Text] [Related]
39. Mitotic rate and younger age as predictors of sentinel lymph node positivity.
Margolin K
Curr Oncol Rep; 2005 Sep; 7(5):375, 376. PubMed ID: 16091198
[No Abstract] [Full Text] [Related]
40. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
